Clinical Trials Directory

Trials / Completed

CompletedNCT04216836

One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Worcester · Academic / Other
Sex
Male
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study investigated the effect of magnesium supplementation on exercise performance and functional recovery in recreational endurance athletes in conjunction with measures of blood glucose, lactate, IL-6 and sIL-6R.

Detailed description

Magnesium status can directly affect circulating glucose concentrations both during and post exercise. In addition, magnesium supplementation has been shown to reduce circulating IL-6 concentrations post exercise in humans. It is conceivable that such observations are linked through the role of IL-6 in glucose regulation, possibly in combination with sIL-6R. Together, magnesium intake may have the potential to effect exercise performance and recovery through glucose availability. This in turn may be connected to the production of IL-6 and sIL-6R which have been established to influence exercise fatigue and perception of pain (muscle soreness).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMagnesium oxideMagnesium capsule
DIETARY_SUPPLEMENTPlaceboCornflour capsule manufactured to mimic the 166.6 mg magnesium capsule.

Timeline

Start date
2018-06-28
Primary completion
2019-03-01
Completion
2019-03-01
First posted
2020-01-03
Last updated
2020-01-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04216836. Inclusion in this directory is not an endorsement.